EligibleTrials

Rheopheresis as Adjuvant Treatment of Calciphylaxis

Recruiting · NCT04654000 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Lille

View the official record on ClinicalTrials.gov →
Chronic kidney disease

Interventions studied

Rheopheresis procedureSham-apheresis

What this trial is about

The investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

29 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.